Healthcare

Volpara Health Technologies Limited (ASX:VHT)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Technology

Market Price : AUD 0.89-0.03 (3.261%)

(as on 2022-01-22 09:28:05 AEDT)

Market Cap : AUD 223.8 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.92 0.91 0.89 0.880L 0.915 H 0.880L 1.715 H
Last Trade 0.89
Change% -3.2609
52 W H/L 1.715/0.880
EBITDA -13.359 M
NPAT After Abnormal Items -16.054 M
Equity 66.829 M
ROE% -24.62%
Total Liabilities 20.028 M
Total Revenue 19.693 M
Cash and Cash Equivalents 29.588 M

Stock Information

Share price 0.89
Market Cap 223.8 M
Price/Gross Cash Flow -32.87
Dividend Yield Excluding Special 0.00%
Ending Shares 251.019 M
52-Week Range 1.715-0.880
P/E ratio 0.000
Sector P/E --
EPS -6.43
EV/EBITDA --
Net Profit Margin (%) -90.77%
Gross Cash Flows Per Share -0.04
Net Gearing -36.89%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.10
Sales Per Share 0.07
Book Value Per Share 0.27

Announcements

Heading Date/Time
Volpara Half Year Results and Investor Webinar Notification  16/11/2021 7:30AM
Volpara Bell Potter Healthcare Conference Presentation  08/11/2021 1:55PM
Appendix 4C Q2FY22 Quarterly Cash Flow Report  26/10/2021 8:28AM
Volpara Quarterly Results and Investor Webinar Notification  19/10/2021 8:26AM
Supplemental disclosure in relation to contract win  08/10/2021 8:22AM
Volpara Q2FY22 Business Update and Morgans Presentation  06/10/2021 8:25AM
Volpara signs largest deal to date with US imaging leader  05/10/2021 9:56AM
Volpara to collaborate with genetics leader Natera  30/09/2021 9:27AM
Notification of cessation of securities - VHT  30/09/2021 8:28AM
Volpara Positioning for Growth in Lung Cancer Screening  28/09/2021 8:25AM
Change in substantial holding  22/09/2021 3:41PM
US lung cancer screening expansion investor webinar  22/09/2021 8:24AM
Volpara to Invest in RevealDX Lung Cancer AI  16/09/2021 10:28AM
Volpara Small and Mid-Cap conference Presentation  13/09/2021 12:26PM
Volpara and Riverain to Partner on Lung Cancer AI  08/09/2021 9:35AM
Initial Director's Interest Notice - A Custin  01/09/2021 12:58PM
Application for quotation of securities - VHT  27/08/2021 2:21PM
Volpara confirms Board changes to drive US growth  19/08/2021 8:06AM
Change of Director's Interest Notice - R Allen  18/08/2021 1:06PM
Notification regarding unquoted securities - VHT  18/08/2021 1:03PM
Final Director's Interest Notice - M Saini  18/08/2021 12:58PM
Results of Meeting  18/08/2021 12:57PM
AGM Presentation 2021  18/08/2021 7:33AM
FDA clears Volpara's next generation imaging software  29/07/2021 8:23AM
Appendix 4C Q1FY22 Quarterly Cash Flow Report  27/07/2021 8:21AM
Annual General Meeting Letter to Shareholders  23/07/2021 10:57AM
Notice of Annual General Meeting/Proxy Form  23/07/2021 10:49AM
VOLPARA COLLABORATES WITH LEADING GENETICS COMPANY, INVITAE  19/07/2021 8:20AM
Volpara Quarterly Results and Investor Webinar Notification  19/07/2021 8:20AM

Similar Companies

Related Articles

Load More

About Company

Volpara Health Technologies Limited (ASX: VHT) is under the healthcare sector and the company develops digital health solutions to enable personalized breast cancer screening software applications. It is a research, manufacturing and development company. The geographical reach of the company extends to America and South America, Asia and Middle East, Europe, Australia and New Zealand. Volpara Enterprise, Volpara Density, Volpara Analytics and Volpara DoseRT provides various offerings under the group’s umbrella. Volpara Solutions Limited, Volpara Solutions Inc and Matakina UK Limited are included in its subsidiaries. The company was incorporated in 2009 and is based out of Panama Street, Wellington, New Zealand.

Corporate Information

company address Level 14-15, 40 Mercer Street, Wellington City, WELLINGTON, ., NEW ZEALAND, 6011

company phone00 64 24 499 6029

company websitehttp://volparasolutions.com

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/03/2021 -- 0.000 0.00%
30/03/2020 -- 0.000 0.00%
30/03/2019 -- 0.000 0.00%
30/03/2018 -- 0.000 0.00%
30/03/2017 -- 0.000 0.00%
30/12/2015 -- 0.000 --

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2022-11-22 2022
Report (Annual) 2022-05-26 2022
Report (Prelim) 2022-05-26 2022

Financials

Breakdown 30/03/2021 30/03/2020 30/03/2019 30/03/2018 30/03/2017
Trading Revenue 18.084 M 12.286 M 4.788 M 2.641 M 1.679 M
Other Revenue 1.609 M 2.154 M 806,358 679,128 189,954
Total Revenue 19.693 M 14.44 M 5.595 M 3.32 M 1.869 M
Interest Income 571,008 751,681 445,316 255,495 247,488
Interest Expenses -134,031 -72,145 -56,502 -4,696 -2,739
Expenses -35.091 M -35.127 M -16.942 M -11.684 M -10.83 M
EBITDA -15.398 M -20.687 M -11.347 M -8.364 M -8.961 M
Depreciation and Amortization -2.836 M -2.184 M -296,877 -170,016 -24,657
Depreciation -781,235 -774,105 -280,597 -170,016 -24,657
Amortisation -2.055 M -1.41 M -16,280 0 0
EBIT -18.234 M -22.871 M -11.644 M -8.534 M -8.985 M
Pre Tax Profit -17.797 M -22.192 M -11.256 M -8.283 M -8.741 M
Tax Expense 1.341 M 1.888 M 11,492 0 0
Net Profit After Tax -16.456 M -20.303 M -11.244 M -8.283 M -8.741 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 401,175 442,624 0 0 0
Reported Net Profit After Abnormal Items -16.054 M -19.861 M -11.244 M -8.283 M -8.741 M
Ending Shares 251.019 M 218.48 M 180.578 M 146.489 M 143.621 M
Weighted Average Shares 247.257 M 210.136 M 176.395 M 146.041 M 128.893 M
EPS After Abnormal Items (cents) -6.49 -9.45 -6.37 -5.67 -6.78
Breakdown 30/03/2021 30/03/2020 30/03/2019 30/03/2018 30/03/2017
Total Current Assets 39.428 M 39.534 M 16.396 M 5.823 M 12.86 M
Total Non Current Assets 47.43 M 31.563 M 1.772 M 1.06 M 140,639
Total Assets 86.858 M 71.097 M 18.168 M 6.882 M 13.001 M
Total Current Liabilities 16.321 M 15.506 M 4.446 M 2.451 M 1.5 M
Total Non Current Liabilities 3.708 M 4.68 M 139,819 209,468 17,351
Total Liabilities 20.028 M 20.185 M 4.586 M 2.66 M 1.518 M
Net Assets 66.829 M 50.912 M 13.582 M 4.222 M 11.483 M
Breakdown 30/03/2021 30/03/2020 30/03/2019 30/03/2018 30/03/2017
Net Operating Cash -12.872 M -15.558 M -10.192 M -7.247 M -7.534 M
Net Invested Cash -21.211 M -38.993 M -9.062 M 9.338 M -10.647 M
Net Financing Cash Flows 38.436 M 53.852 M 19.818 M -113,657 19.457 M
Beginning Cash 3.372 M 4.009 M 3.201 M 1.199 M 252,968
End Cash Position 7.228 M 3.581 M 3.938 M 3.139 M 1.165 M
Exchange Rate Adjustments -497,567 271,034 173,338 -36,633 -363,470
Other Cash Adjustments 0 0 0 0 0
Ending Cash 7.228 M 3.581 M 3.938 M 3.139 M 1.165 M

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK